CEREGUARD

PHARMACEUTICAL PREPARATIONS FOR MEDICAL, THERAPEUTIC AND/OR PROPHYLACTIC USE IN THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM; AND DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE

TREATMENT OF PROTEIN-LIKE SUBSTANCES, NAMELY, CHEMICAL TREATMENT FOR MEDICAL USE, RESEARCH OR DIAGNOSTIC PURPOSES; TREATMENT OF PROTEIN-LIKE SUBSTANCES WITH CHARACTERISTICS THAT HAVE A POSITIVE INFLUENCE ON THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM, NAMELY, CHEMICAL TREATMENT

SCIENTIFIC RESEARCH OF PROTEIN-LIKE SUBSTANCES WITH CHARACTERISTICS THAT HAVE A POSITIVE INFLUENCE ON THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM; AND RESEARCH, NAMELY, SCIENTIFIC, CHEMICAL, MEDICAL, AND TESTING RESEARCH OF PROTEIN-LIKE SUBSTANCES WITH CHARACTERISTICS THAT HAVE A POSITIVE INFLUENCE ON THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM FOR DIAGNOSTIC PURPOSES